The Food and Drug Administration has approved Medtronic's Endeavor zotarolimus-eluting coronary stent system to be used in the treatment of coronary artery disease. It is the first new drug-eluting stent to be approved by the FDA since 2004.
Trending:
FDA greenlights first drug-eluting stent in more than three years